Drug Price Increases That Exceed Inflation Are Costing Medicare Part D Billions

This AARP Public Policy Institute Spotlight finds that total Medicare Part D spending on 50 top brand-name drugs was $38 billion higher between 2015 and 2019 than it would have been if drug manufacturers had not increased their prices faster than the corresponding rate of inflation.

The Health 202: Democrats seek to tack drug pricing onto an infrastructure package

The Biden administration hasn’t embraced various drug-price-lowering measures pushed by former president Donald Trump.

But the pharmaceutical industry has something else to worry about.

Biogen faces tough questions over $56K-a-year price of newly approved Alzheimer’s drug

Biogen on Tuesday faced tough questions from Wall Street analysts over the $56,000 annual cost of its newly approved Alzheimer’s drug, Aduhelm.

Rep. Katie Porter Presses AbbVie CEO About Increased Drug Prices

Rep. Katie Porter of Orange County is a champion for patients across America, and a huge advocate for affordable prescriptions. Here, she asks a Pharma CEO the tough questions on behalf of consumers.

It’s Simple: Medications Don’t Work if People Can’t Afford Them

Albuquerque resident Jeanne Hamrick explains how out-of-pocket expenses for her medication have impacted her life. With so many New Mexicans experiencing serious hardships due to the cost of their essential prescriptions, there has never been a better time for drug pricing reform.

‘There are no alternatives’: As Pfizer discontinues an old glaucoma drug, a small group of patients struggles to cope

Next month, an eye drop that Carol Vaghar has taken for the past few years to manage a rare form of glaucoma will no longer be available, leaving her little choice but to consider potentially risky surgery to maintain the pressure in her eyes. Pfizer says this drug is too hard for them to manufacture.

Pfizer eyes higher prices for COVID-19 vaccine after the pandemic wanes: exec, analyst

Amid the high-stakes fight against COVID-19, a company at the forefront of the vaccine effort is laying plans to hike prices after the crisis. A top Pfizer exec said the drugmaker aims to charge more after the "pandemic pricing environment," and an influential analyst says the company could be eying prices 3 to 4 times higher.

HB 154 will help lower prescription drug costs

HB 154 is a must for NM consumers and community members.

"New Mexico can do better. The state regulates the cost of health insurance, electricity and other critical utilities, and it ought to look out for consumers of prescription medications as well." - Jeanne Hamrick, Albuquerque resident

Rep. Katie Porter Outlines Why Competition is Critical in the Pharmaceutical Industry

Competition is critical for the pharmaceutical industry...Rep. Katie Porter of California explains why.

Consumer and health advocates call for fast passage of Prescription Drug Affordability Act

ALBUQUERQUE, NM – Citing data that big drug companies have taken advantage of the COVID-19 pandemic to raise prices on hundreds of medications, AARP New Mexico, Health Action New Mexico and a statewide coalition of health experts, patient advocates and consumers today lauded the introduction of the Prescription Drug Affordability Act (House Bill 154) and […]